AgingResearch.NewsJoin free

All fractures

There is 1 paper on all fractures in aging research: none in people yet, 1 review. The newest story, Nov 11, 2026: “Bisphosphonates linked to more repeat fractures than denosumab”.

Disease

1 paper studies it13,681 more mention it1 finding

342 new papers in 30 daysSee all 13,682 papers on all fractures

“statin treatment was significantly associated with reduced risk of all fractures (RR 0.80, 95% CI 0.72-0.88)”
Effects of Statins on Relative Risk of Fractures for Older Adults: An Updated Systematic Review With Meta-AnalysisJournal of the American Medical Directors Association2019doi:10.1016/j.jamda.2019.06.027

Associations

1

Statins

downin humans1RR 0.8

1 study

  1. Statins are linked with a lower risk of all fractures in humans (observational studies) (RR 0.80, 95% CI 0.72-0.88).

    “statin treatment was significantly associated with reduced risk of all fractures (RR 0.80, 95% CI 0.72-0.88)”

    Humansobservational studies

    Effects of Statins on Relative Risk of Fractures for Older Adults: An Updated Systematic Review With Meta-Analysis

    Journal of the American Medical Directors Association

More on Statins

Latest

Journal of Bone Oncology

Calcium, vitamin D not tied to less bone loss on aromatase inhibitors

Over five years, spine bone density fell 11.1% with calcium and vitamin D and 11.4% without supplements in postmenopausal women taking breast cancer hormone therapy.Over five years, spine bone density fell 11.1% with calcium and vitamin D and 11.4% without supplements in postmenopausal women taking breast cancer hormone therapy.

Cohort · 636 peopleBone loss
Paper
Journal of Orthopaedics and Traumatology

Hip surgery from the front not linked to fewer deaths

One-year death rates were 26% with surgery from the front, versus 26%, 26% and 27% with three other approaches.One-year death rates were 26% with surgery from the front, versus 26%, 26% and 27% with three other approaches.

Cohort · 21,393 peopleInterventions
Paper
JAMA Network Open

Bisphosphonates linked to more repeat fractures than denosumab

Women starting bisphosphonates had 52.7 repeat fractures per 1,000 person-years, versus 46.5 with denosumab, during three years of follow-up.Women starting bisphosphonates had 52.7 repeat fractures per 1,000 person-years, versus 46.5 with denosumab, during three years of follow-up.

Cohort · 15,099 peopleBones and joints
Paper

See all 13,682 papers on all fractures

Related